Biotech Values

[DewDiligence]

ADXS fully-diluted share count @7/31/17=48.2M:

https://www.sec.gov/Archives/edgar/data/1100397/000149315217010463/form10q.htm#a_003 (FY3Q17 10-Q)
https://www.sec.gov/Archives/edgar/data/1100397/000149315217002549/forms-3a.htm (3/19/17 prospectus for shelf registration)

The 48.2M figure consists of:

41.0M basic shares on 7/31/17 balance sheet (+0.6M since 4/30/17)
3.1M warrants @2/6/17(avg exercise price=$5.04) (3/19/17 prospectus, page S-5)
3.4M options (avg exercise price=$13.31) (ibid)
0.7M shares underlying RSUs (ibid)
==
48.2M fully-diluted shares